Research study · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · 2026
Δ9-Tetrahydrocannabinol Alters Limbic and Frontal Functional Brain Connectomes Among Young Adult Cannabis Users
Verified on PubMed Oxford CEBM Level 1B: Randomized Controlled Trial
A 2026 randomized controlled trial in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging tested tetrahydrocannabinol in cannabis use. The results were mixed, and the drug did change brain activity in several areas. This study shows that a single moderate dose of THC changed how several brain networks communicate in healthy occasional users, and it adds to.
In plain language
Study overview
Researchers studied 33 healthy young adults in their early twenties who used cannabis occasionally. Each person took a capsule with a moderate amount of synthetic THC (the main intoxicating ingredient in cannabis, given as a prescription form) on one visit and an inactive capsule on another, and their brain activity was scanned at rest while they were high.
Findings
The results were mixed, and the drug did change brain activity in several areas. The capsule with the active ingredient made people feel clearly high, and their brain scans showed quieter communication within several brain networks, including areas tied to reward, senses, and body awareness.
Explore Dr. Caplan's interactive tool detailing cytochrome P450 pathways, clinical titration intervals, and physician surveillance rules.
The deeper readScientific analysis
BACKGROUND: Cannabis use among young adults has reached the highest levels ever recorded. Evidence indicates that acute Δ9-tetrahydrocannabinol (THC) disrupts brain connectivity. Few studies have examined this on a whole-brain level. We examined the effects of a single moderate dose of THC on resting-state functional brain networks among young adult cannabis users. METHODS: In a within-subject, double-blind, randomized study, 33 healthy occasional cannabis users received THC (7.5 mg, oral) and placebo before completing resting-state functional magnetic resonance imaging (rs-fMRI) during peak intoxication. Group-information–guided independent component analysis was performed on resting-state brain data to identify whole-brain networks associated with each scan. Within-samples t tests assessed for differences in intrinsic network functional connectivity and between-network functional connectivity after THC versus placebo. Additional linear models examined relationships between brain connectivity, subjective drug effects, and past-month cannabis use. RESULTS: THC reduced within-network intrinsic connectivity in corticostriatal circuits and other networks associated with sensory systems, interoceptive experiences, and spatial reasoning. THC reduced connectivity between 2 networks characterized by the anterior cingulate cortex and dorsal insula regions as well as the ventral insula and lingual gyrus, respectively. Network connectivity during THC (vs. placebo) was not related to subjective measures of drug effect or recent cannabis use. CONCLUSIONS: Our findings add to a growing literature showing that THC decreases rs-fMRI throughout the brain, impacting networks linked to the many behavioral and perceptual changes associated with THC. Future work is needed to extend these findings to clinical samples and to assess the extent to which these networks are associated with negative outcomes of chronic THC use.
The paper
Citation
Anderson Z, Gunn M, Jones E, Ajilore O, Phan KL, de Wit H, et al. Δ9-Tetrahydrocannabinol Alters Limbic and Frontal Functional Brain Connectomes Among Young Adult Cannabis Users. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2026). PubMed 40957507 · DOI
Limitations the authors noted
Small, homogeneous sample (n=33) of occasional cannabis users; limited heterogeneity in mood, use history, and clinical status. Few nonusers or heavy users, limiting power to detect cannabis use history effects. Single dose (7.5 mg dronabinol); dose and synthetic form may not reflect street cannabis or self-administered products. Reliability concerns for single short resting-state scans. No participants with current or most lifetime psychopathology; few with anxiety or depression history. Between-network finding significant only at uncorrected threshold. Random assignment order and allocation concealment not described; no power calculation reported. One participant used cannabis hours before a session; others used more than 24 hours prior.
In practice
Why this matters
This study shows that a single moderate dose of THC changed how several brain networks communicate in healthy occasional users, and it adds to a growing body of work pointing the same way. It does not show that these changes cause harm, that they persist, or that they would appear with other doses, cannabis products, or people with mental health conditions, and the sample was small and short-term. A reader should treat it as a clear picture of what THC does to brain activity during intoxication, not as evidence about lasting effects or safety.
Frequently asked questions
Clinical Questions & Answers
What were the primary clinical findings regarding cannabinoids and Cannabis use?
The results were mixed, and the drug did change brain activity in several areas. The capsule with the active ingredient made people feel clearly high, and their brain scans showed quieter communication within several brain networks, including areas tied to reward, senses, and body awareness.
What study limitations or clinical safeguards should patients keep in mind?
Small, homogeneous sample (n=33) of occasional cannabis users; limited heterogeneity in mood, use history, and clinical status. Few nonusers or heavy users, limiting power to detect cannabis use history effects. Single dose (7.
Browse related research
Condition: Cannabis use Topic: THC
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on October 17, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.
